Search Options Stock News and Analysis from Schaeffer's

This Biotech's Bull Signal Has Never Been Wrong

https://www.schaeffersresearch.com/content/analysis/2022/11/14/this-biotechs-bull-signal-has-never-been-wrong

11/14/2022 1:15 PM

Biotechnology concern Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been a standout during the past year, joining some of its sector peers in notable annual returns. The security surged to a...

Is Vertex Pharmaceuticals Stock Bound for a Pop?

https://www.schaeffersresearch.com/content/analysis/2022/03/14/is-vertex-pharmaceuticals-stock-bound-for-a-pop

3/14/2022 2:14 PM

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up 1.6% at $240.25 at last check. Shares saw a positive post-earnings reaction in late January, and then surged to their highest level since Octobe...

VRTX Plummets After Ditching Experimental Drug

https://www.schaeffersresearch.com/content/news/2021/06/11/vrtx-plummets-after-ditching-experimental-drug

6/11/2021 10:25 AM

The shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) are down 11.7% at $191.50 at last check, after the company announced an experimental drug it was developing to treat a rare genetic cond...

3 Earnings Winners to Watch Today

https://www.schaeffersresearch.com/content/news/2020/01/31/3-earnings-winners-to-watch-today

1/31/2020 10:53 AM

Earnings have been in focus all week on Wall Street, and that's continuing today, with a number of big names making notable moves after their quarterly reports. Leading the way of course is Amazon.co...

Crispr Therapeutics Stock Pops on Vertex Stake

https://www.schaeffersresearch.com/content/news/2018/12/24/crispr-therapeutics-stock-pops-on-vertex-stake

12/24/2018 11:43 AM

Crispr Therapeutics AG (NASDAQ:CRSP) is trading up 9.9% at $24.98 today, after it was revealed Friday evening that cystic fibrosis specialist Vertex Pharmaceuticals (VRTX) took a 10.1% stake in the ge...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity